Everolimus as second-line therapy for metastatic renal cell carcinoma: final results of phase IV study MARC-2.

2. Oktober 2018

M. Staehler, D. Christoph, M. Stöckle, J. Harde, A. Stenzl, D. Klein, I. Benz-Rüd, V. Grünwald, 2018.

Oncol Res Treat 41 (suppl 4)(P610).